Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1994-11-02
1997-10-28
Marschel, Ardin H.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 253, 514 44, C07H 1900, C07H 2102, C07H 2100, A01N 4304
Patent
active
056819404
ABSTRACT:
A number of modified nucleosides are disclosed composed of modified sugar moieties which contain substituents at C1 and C4 positions, or branched substituents at C3 and C5 positions of deoxyribose or ribose. Each nucleoside is converted to or properly protected and then converted to the corresponding phosphoramidites. These phosphoramidites are used to assemble oligonucleotides in which there is at least one forenoted nucleosides. These sugar modified oligonucleotides have the potential to be used as antisense therapies since they are expected to enhance nuclease resistance and cellular uptake while they maintain sequence-specificity and affinity to nucleic acid targets in vitro or in vivo.
REFERENCES:
patent: 5446137 (1995-08-01), Maag et al.
Rabow L. and Stubbe, J., "Identification of the Alkaline-Labile Product Accompanying Cytosine Release during Bleomycin-Mediated Degradation of d(CGCGCG)", J. Am. Chem. Soc. 1986, 108, 7130-7131 (dated 1986).
Ramasamy Kandasamy
Seifert Wilfried E.
Wang Guangyi
ICN Pharmaceuticals
Marschel Ardin H.
Riley Jezia
LandOfFree
Sugar modified nucleosides and oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sugar modified nucleosides and oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sugar modified nucleosides and oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1027148